Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4IX8

Crystal structure of Tyrosine aminotransferase from Leishmania infantum

Summary for 4IX8
Entry DOI10.2210/pdb4ix8/pdb
DescriptorTyrosine aminotransferase, CHLORIDE ION (3 entities in total)
Functional Keywordsssgcid, tyrosine aminotransferase, pyridoxal phosphate, seattle structural genomics center for infectious disease, transferase
Biological sourceLeishmania infantum
Total number of polymer chains2
Total formula weight99968.12
Authors
Seattle Structural Genomics Center for Infectious Disease (SSGCID) (deposition date: 2013-01-24, release date: 2014-03-26, Last modification date: 2023-11-15)
Primary citationMoreno, M.A.,Abramov, A.,Abendroth, J.,Alonso, A.,Zhang, S.,Alcolea, P.J.,Edwards, T.,Lorimer, D.,Myler, P.J.,Larraga, V.
Structure of tyrosine aminotransferase from Leishmania infantum.
Acta Crystallogr F Struct Biol Commun, 70:583-587, 2014
Cited by
PubMed Abstract: The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an important role in the metabolism of trypanosomatids, catalyzing the first step in the degradation pathway of aromatic amino acids, which are ultimately converted into their corresponding L-2-oxoacids. Unlike the enzyme in Trypanosoma cruzi and mammals, L. infantum TAT (LiTAT) is not able to transaminate ketoglutarate. Here, the structure of LiTAT at 2.35 Å resolution is reported, and it is confirmed that the presence of two Leishmania-specific residues (Gln55 and Asn58) explains, at least in part, this specific reactivity. The difference in substrate specificity between leishmanial and mammalian TAT and the importance of this enzyme in parasite metabolism suggest that it may be a useful target in the development of new drugs against leishmaniasis.
PubMed: 24817714
DOI: 10.1107/S2053230X14007845
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.35 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon